HIGHLIGHTS
- who: Ayumi Yoshifuji from the Tokyo, Japan have published the Article: Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy, in the Journal: (JOURNAL) of December/28,/2021
- what: The survey showed that only 25.8% of the facilities had experience with tocilizumab.
- how: The results of this survey showed that steroid pulse therapy was used in 48.5% of facilities. In Japan the survey revealed that steroid pulse therapy is used more frequently in patients with worsening symptoms of moderate II or higher and in patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.